Position in SNY
as of Jun 30, 2026
· filed Aug 4, 2026
Position Value
$164,021,044
-$9,392,458 QoQ
Shares Held
3,844,844
+6.8% QoQ
Ownership
0.160%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#10
of 712 holders
Holding Since
Sep 2021
20 quarters on record
Voting authority
Sole 50%
Shared 0%
None 50%
Common Shares in SNY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Boston Partners holds $3,635,506,449 across 12 Drug Manufacturers - General names. SNY ranks #7 (4.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
4,784,316 | $1,203,925,277 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
6,017,958 | $760,308,811 | |
| 3 | AZN |
Astrazeneca PLC
|
3,177,627 | $602,541,630 | |
| 4 | JNJ |
Johnson & Johnson
|
1,113,805 | $282,873,054 | |
| 5 | BIIB |
Biogen Inc.
|
1,263,429 | $272,976,467 | |
| 6 | AMGN |
Amgen Inc
|
637,923 | $231,004,675 | |
| 7 | SNY |
Sanofi
This page
|
3,844,844 | $164,021,044 | |
| 8 | MRK |
Merck & Co., Inc.
|
629,240 | $80,857,340 |
All Filings in SNY
Export CSV
20 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $164,021,044 | 3,844,844 | Shares | Defined | 2026-08-04 | |
| 2026-03-31 | $173,413,502 | 3,599,284 | Shares | Other | 2026-05-11 | |
| 2025-12-31 | $176,129,080 | 3,634,525 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $173,549,632 | 3,676,899 | Shares | Other | 2025-11-13 | |
| 2025-06-30 | $192,705,207 | 3,988,930 | Shares | Other | 2025-08-12 | |
| 2025-03-31 | $226,789,249 | 4,089,240 | Shares | Other | 2025-05-13 | |
| 2024-12-31 | $260,274,688 | 5,396,531 | Shares | Other | 2025-02-11 | |
| 2024-09-30 | $166,865,244 | 2,895,458 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $144,784,892 | 2,984,025 | Shares | Other | 2024-08-14 | |
| 2024-03-31 | $635,027,185 | 13,066,403 | Shares | Other | 2024-05-28 | |
| 2023-12-31 | $648,118,456 | 13,032,746 | Shares | Defined | 2024-02-07 | |
| 2023-09-30 | $685,898,110 | 12,787,064 | Shares | Defined | 2023-11-08 | |
| 2023-06-30 | $706,882,435 | 13,114,702 | Shares | Other | 2023-08-10 | |
| 2023-03-31 | $976,618,216 | 17,945,943 | Shares | Other | 2023-05-09 | |
| 2022-12-31 | $883,697,559 | 18,246,904 | Shares | Defined | 2023-02-08 | |
| 2022-09-30 | $673,836,023 | 17,723,199 | Shares | Defined | 2022-11-09 | |
| 2022-06-30 | $595,391,168 | 11,900,683 | Shares | Other | 2022-08-10 | |
| 2022-03-31 | $578,723,371 | 11,272,368 | Shares | Other | 2022-05-10 | |
| 2021-12-31 | $347,872,805 | 6,943,569 | Shares | Defined | 2022-02-04 | |
| 2021-09-30 | $221,340,978 | 4,591,184 | Shares | Other | 2021-11-05 | |
| No filing history on record for this holder in this stock. | ||||||